These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 17450033)
1. Clinical epidemiology of primary biliary cirrhosis: incidence, prevalence, and impact of therapy. Lazaridis KN; Talwalkar JA J Clin Gastroenterol; 2007; 41(5):494-500. PubMed ID: 17450033 [TBL] [Abstract][Full Text] [Related]
2. The new epidemiology of primary biliary cirrhosis. Griffiths L; Dyson JK; Jones DE Semin Liver Dis; 2014 Aug; 34(3):318-28. PubMed ID: 25057954 [TBL] [Abstract][Full Text] [Related]
3. The limitations and hidden gems of the epidemiology of primary biliary cirrhosis. Podda M; Selmi C; Lleo A; Moroni L; Invernizzi P J Autoimmun; 2013 Oct; 46():81-7. PubMed ID: 23871640 [TBL] [Abstract][Full Text] [Related]
4. Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome. Corpechot C; Chazouillères O; Poupon R J Hepatol; 2011 Dec; 55(6):1361-7. PubMed ID: 21703194 [TBL] [Abstract][Full Text] [Related]
5. Targeted Metabolomics Reveals a Protective Role for Basal PPARα in Cholestasis Induced by α-Naphthylisothiocyanate. Dai M; Hua H; Lin H; Xu G; Hu X; Li F; Gonzalez FJ; Liu A; Yang J J Proteome Res; 2018 Apr; 17(4):1500-1508. PubMed ID: 29498526 [TBL] [Abstract][Full Text] [Related]
6. New developments in the treatment of primary biliary cholangitis - role of obeticholic acid. Jhaveri MA; Kowdley KV Ther Clin Risk Manag; 2017; 13():1053-1060. PubMed ID: 28860789 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of JNK signalling mediates PPARα-dependent protection against intrahepatic cholestasis by fenofibrate. Dai M; Yang J; Xie M; Lin J; Luo M; Hua H; Xu G; Lin H; Song D; Cheng Y; Guo B; Zhao J; Gonzalez FJ; Liu A Br J Pharmacol; 2017 Sep; 174(18):3000-3017. PubMed ID: 28646549 [TBL] [Abstract][Full Text] [Related]
12. Risk factors for hepatic decompensation in patients with primary biliary cirrhosis. Shi TY; Zhang LN; Chen H; Wang L; Shen M; Zhang X; Zhang FC World J Gastroenterol; 2013 Feb; 19(7):1111-8. PubMed ID: 23467321 [TBL] [Abstract][Full Text] [Related]
13. Role of autoimmunity in primary biliary cirrhosis. Shi TY; Zhang FC World J Gastroenterol; 2012 Dec; 18(48):7141-8. PubMed ID: 23326118 [TBL] [Abstract][Full Text] [Related]
14. Observation on therapeutic efficacy of ursodeoxycholic acid in Chinese patients with primary biliary cirrhosis: a 2-year follow-up study. Zhu J; Shi Y; Zhou X; Li Z; Huang X; Han Z; Wang J; Wang R; Ding J; Wu K; Han Y; Fan D Front Med; 2013 Jun; 7(2):255-63. PubMed ID: 23179137 [TBL] [Abstract][Full Text] [Related]
15. Trends in liver transplantation for primary biliary cirrhosis in the Netherlands 1988-2008. Kuiper EM; Hansen BE; Metselaar HJ; de Man RA; Haagsma EB; van Hoek B; van Buuren HR BMC Gastroenterol; 2010 Dec; 10():144. PubMed ID: 21172005 [TBL] [Abstract][Full Text] [Related]
16. Primary Biliary Cirrhosis-Related Autoimmune Hemolytic Anemia: Three Case Reports and Review of the Literature. Tian Y; Wang C; Liu JX; Wang HH Case Rep Gastroenterol; 2009 Aug; 3(2):240-247. PubMed ID: 21103282 [TBL] [Abstract][Full Text] [Related]